David Calhoun to Animals
This is a "connection" page, showing publications David Calhoun has written about Animals.
Connection Strength
0.210
-
Acelajado MC, Hughes ZH, Oparil S, Calhoun DA. Treatment of Resistant and Refractory Hypertension. Circ Res. 2019 03 29; 124(7):1061-1070.
Score: 0.046
-
Meghdari M, Gao N, Abdullahi A, Stokes E, Calhoun DH. Carboxyl-terminal truncations alter the activity of the human a-galactosidase A. PLoS One. 2015; 10(2):e0118341.
Score: 0.034
-
Calhoun DA, Sharma K. The role of aldosteronism in causing obesity-related cardiovascular risk. Cardiol Clin. 2010 Aug; 28(3):517-27.
Score: 0.025
-
Pimenta E, Calhoun DA. Aldosterone and metabolic dysfunction: an unresolved issue. Hypertension. 2009 Apr; 53(4):585-6.
Score: 0.023
-
Gaddam KK, Pimenta E, Husain S, Calhoun DA. Aldosterone and cardiovascular disease. Curr Probl Cardiol. 2009 Feb; 34(2):51-84.
Score: 0.023
-
Pimenta E, Calhoun DA. Aldosterone, dietary salt, and renal disease. Hypertension. 2006 Aug; 48(2):209-10.
Score: 0.019
-
Zaman MA, Oparil S, Calhoun DA. Drugs targeting the renin-angiotensin-aldosterone system. Nat Rev Drug Discov. 2002 Aug; 1(8):621-36.
Score: 0.014
-
Grassi G, Calhoun DA. Sympathetic-vascular interactions: further evidence in kidney transplantation. J Hypertens. 2002 Mar; 20(3):379-81.
Score: 0.014
-
Guichard JL, Clark D, Calhoun DA, Ahmed MI. Aldosterone receptor antagonists: current perspectives and therapies. Vasc Health Risk Manag. 2013; 9:321-31.
Score: 0.008
-
Pimenta E, Calhoun DA, Oparil S. Sleep apnea, aldosterone, and resistant hypertension. Prog Cardiovasc Dis. 2009 Mar-Apr; 51(5):371-80.
Score: 0.006